SI Shoulder Innovations, Inc.
Healthcare$15.06+3.15%ClosedMarket Cap: $312.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.27
P/S
5.62
EV/EBITDA
-7.03
DCF Value
$-28.90
FCF Yield
-14.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
76.8%
Operating Margin
-57.5%
Net Margin
-81.8%
ROE
-35.3%
ROA
-27.5%
ROIC
-20.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $16.7M | 77.7% | $-9.0M | $-8.4M | $— | — |
| Q4 null | $14.4M | 76.7% | $-8.5M | $-7.8M | $— | — |
| FY null | $47.3M | 76.5% | $-26.3M | $-40.4M | $— | — |
| Q3 null | $11.8M | 76.2% | $-7.6M | $-8.7M | $— | — |
| Q2 null | $11.0M | 76.2% | $-5.9M | $-19.2M | $— | — |
| Q1 null | $10.1M | 76.9% | $-4.3M | $-4.7M | $— | — |
| Q4 null | $8.7M | 77.6% | $-3.5M | $-3.8M | $— | — |
| FY null | $31.6M | 77.0% | $-14.7M | $-15.6M | $— | — |
| Q3 null | $7.5M | 76.5% | $-3.9M | $-4.1M | $— | — |
| Q2 null | $8.3M | 76.9% | $-4.0M | $-4.2M | $— | — |
| Q1 null | $7.2M | 76.8% | $-3.3M | $-3.6M | $— | — |
| Q4 2023 | $6.8M | 79.5% | $-2.4M | $-2.5M | $-0.13 | — |